REACTIONS OF N-(2,2-DICHLORO-1-CYANOETHENYL)-N'-METHYL(PHENYL)UREAS
989
128.6, 129.5, 132.2, 153.0 (С=О) (all the signals are
broadened). Mass spectrum, m/z: 256 [M + H]+. Found,
%: С 46.83; Н 2.84; Cl 27.61; N 16.60. С10Н7Сl2N3O.
Calculated, %: С 46.90; Н 2.76; Cl 27.69; N 16.41.
149°С. IR spectrum, ν, cm–1: 1476, 1674, 1752 (C=O),
2994–3297 (NH). Н NMR spectrum, δ, ppm: 2.15 s
1
(0.8×6Н, СН3), 2.30 s (0.2×6Н, СН3), 2.82 s (0.2×3Н,
СН3), 2.87 s (0.80×3Н, СН3), 6.62 s (0.8Н, СН), 6.66 s
(0.2Н, CН), 7.86 s (0.8Н, NH), 8.09 s (0.2Н, NН),
8.39 br.s (1Н, NН). 13C NMR spectrum, δC, ppm: 25.0
(CH3), 38.8 (CH3), 74.0, 82.3, 157.7, 161.4. Mass
spectrum, m/z: 239 [M + H]+. Found, %: С 35.27; Н
5.19; Cl 29.54; N 23.63. С7Н12Сl2N4O. Calculated, %:
С 35.16; Н 5.06; Cl 29.65; N 23.43.
4-(Dichloromethyl)-5-imino-1-methyl-4-(methyl-
amino)imidazolidin-2-one (9a). 20% solution (5 mL)
of methylamine in methanol was added with stirring at
20–25°C to a suspension of compound 5 (1.0 g,
0.005 mol) in methanol (5 mL). The mixture was
stirred for 12 h, and a clear solution was formed. The
solvent was removed under reduced pressure, and the
residue was treated with 10 mL of water. The
precipitate was filtered off and recrystallized from
propan-2-ol. Yield 62%, mp 146–148°C. IR spectrum,
ν, cm–1: 1461, 1662, 1737 (C=O), 3000–3321 (NH). 1Н
NMR spec-trum, δ, ppm: 2.05 s (3Н, СН3), 2.80 br.s
(1Н, NH), 2.85 s (3Н, CH3), 6.13 s (0.15Н, СН), 6.38 s
(0.85Н, CН), 8.10 s (1Н, NН), 8.29 s (1Н, NН). 13C
NMR spectrum, δС, ppm: 25.1 (CH3), 29.1 (CH3),
75.8, 80.8, 157.6, 162.5. Mass spectrum, m/z: 225
[M + H]+. Found, %: С 31.84; Н 4.27; Cl 31.47; N
24.93. С6Н10Сl2N4O. Calculated, %: С 32.02; Н 4.48;
Cl 31.50; N 24.89.
tert-Butyl-4-[4-(dichloromethyl)-5-imino-1-methyl-
2-oxoimidazolidin-4-yl]piperazine-1-carboxylate (9d).
Yield 51%, mp 154–156°С. IR spectrum, ν, cm–1:
1402, 1431, 1453, 1479, 1670, 1745 (C=O), 3087–
1
3307 (NH). Н NMR spectrum, δ, ppm: 1.37 s (9Н,
СН3), 2.23–2.51 m (2Н, СН2), 2.81 s (0.3×3Н, СН3),
2.86 s (0.7×3Н, СН3), 3.31 m (6Н, СН2), 6.70 s (1Н,
CН), 7.90 s (0.7H, NH), 8.14 s (0.3Н, NН), 8.45 s (1Н,
NН). 13C NMR spectrum, δC, ppm: 25.0 (CH3), 28.5
(CH3), 43.6, 46.3, 73.5, 79.5, 81.9, 154.0, 157.4, 160.8.
Mass spectrum, m/z: 380 [M + H]+. Found, %: С
44.28; Н 5.99; Cl 18.82; N 18.50. С14Н23Сl2N5O3.
Calculated, %: С 44.22; Н 6.10; Cl 18.65; N 18.42.
4-(Dichloromethyl)-5-imino-1-methyl-4-(morpholin-
4-yl)imidazolidin-2-one (9e). Yield 58%, mp 115–
117°С. IR spectrum, ν, cm–1: 1451, 1481, 1675, 1758
4-(Alkylamino)-4-(dichloromethyl)-5-imino-1-
methylimidazolidin-2-ones 9b–9e. Triethylamine
(2.11 mL, 0.015 mol) and the appropriate amine
(0.005 mol) were added in sequence at 20–25°C to a
stirred suspension of compound 5a (1.0 g, 0.005 mol)
in methanol (10 mL). The mixture was stirred for 12 h,
and a clear solution was formed. The solvent was
removed under reduced pressure, and the residue was
treated with 10 mL of water. The precipitate was
filtered off and recrystallized from propan-2-ol.
1
(C=O), 3077–3326 (NH). Н NMR spectrum, δ, ppm:
2.27–2.45 m (2Н, СН2), 2.82 s (0.3×3H, CH3), 2.86 s
(0.7×3Н, СН3), 3.30–3.40 m (2Н, СН2), 3.48–3.62 m
(4Н, СН2), 6.70 s (1Н, CН), 7.91 s (0.7H, NH), 8.18 s
(0.3Н, NН), 8.48 s (1Н, NН). 13C NMR spectrum, δC,
ppm: 25.0 (CH3), 46.7, 66.5, 73.4, 81.9, 157.5, 160.7.
Mass spectrum, m/z: 281 [M + H]+. Found, %: С
38.28; Н 5.16; Cl 25.08; N 19.99. С9Н14Сl2N4O2.
Calculated, %: С 38.45; Н 5.02; Cl 25.22; N 19.93.
4-(Benzylamino)-4-(dichloromethyl)-5-imino-1-
methylimidazolidin-2-one (9b). Yield 57%, mp 178–
180°С. IR spectrum, ν, cm–1: 1400, 1475, 1669, 1741
X-Ray diffraction study of a crystal of 9b (0.15 ×
0.18 × 0.28 mm) was carried out at room temperature
with a Bruker Smart Apex II diffractometer (MoKα-
radiation, graphite monochromator, θmax 26.42°, –12 ≤
h ≤ 11, –17 ≤ k ≤ 15, –13 ≤ l ≤ 13). In total, 15213
reflections were collected, of which 2908 were inde-
pendent (R-factor 0.0737). Absorption was corrected
for in SADABS software by the multiscanning method
(Tmin/Tmax = 0.8365/0.9349). Crystals of compound 9b
were monoclinic, the unit cell parameters: space group
Р21/n, а 9.8504(18), b 13.725(3), c 11.139(3) Å,
β 109.691(4)°, V 1417.9(5) Å3, Z 4, dcalc 1.411,
μ 0.455 mm–1, F(000) 624. The structure was solved
via the direct method and refined by the least squares
method in the full-matrix anisotropic approximation
1
(C=О), 3030–3274 (NH). Н NMR spectrum, δ, ppm:
3
2.87 s (3Н, СН3), 3.12 br. t (1H, NH, JHH = 7.2 Hz),
3
2
3.53 d. d (1H, CH2, JHH = 7.2, JHH = 12.8 Hz), 3.60
3
2
d. d (1H, CH2, JHH = 7.2, JHH = 12.8 Hz), 6.25 s
(0.15Н, СН), 6.40 s (0.85Н, CН), 7.24–7.33 m (5Н,
С6Н5), 8.25 br.s (1Н, NН), 8.47 s (1Н, NН). 13C NMR
spectrum, δС, ppm: 25.3 (CH3), 46.9 (CH2), 75.9, 80.3,
127.6, 128.7, 128.9, 139.8, 157.6, 162.9. Mass spec-
trum, m/z: 301 [M + H]+. Found, %: С 47.94; Н 4.47;
Cl 23.45; N 18.53. С12Н14Сl2N4O. Calculated, %: С
47.86; Н 4.69; Cl 23.54; N 18.60.
4-(Dimethylamino)-4-(dichloromethyl)-5-imino-
1-methylimidazolidin-2-one (9c). Yield 43%, mp 147–
RUSSIAN JOURNAL OF GENERAL CHEMISTRY Vol. 87 No. 5 2017